Additionally, synergistic anti‐tumor effects have been observed upon using ZD55‐IL‐24, an oncolytic adenovirus containing IL‐24, in combination with radiation in prostate cancer models (Mao et al. 2020). Here, IL24 is linked to Familial prostate cancer.